Aizant Drug Research Solutions is an integrated pharmaceutical development partner supporting API R&D, formulation development, analytical development, clinical research, CDMO, CMO, and finished dosage manufacturing programs. The company is based in India and supports global pharmaceutical and biotech sponsors across multiple stages of drug development.

Overview

Aizant is built for sponsors that need a single development partner across formulation, analytical, clinical, and manufacturing workflows. Their model brings together API research, drug product development, bioanalytical support, clinical research, regulatory support, and commercial manufacturing under one organization.

For pharmaceutical and biotech teams working on small molecules, generics, specialty products, complex formulations, or clinical-stage development programs, Aizant provides a flexible outsourcing path from early development through scale-up and commercialization.

Accreditations & Compliance

Aizant’s public materials describe three globally accredited facilities supporting drug development, manufacturing, and clinical research activities. Their capabilities span R&D, GMP manufacturing, clinical research, bioanalysis, and regulatory-aligned documentation.

Aizant also reported a successful USFDA audit with zero Form 483 observations for its Clinical Unit 2 in July 2024.

Their clinical development division has also been inspected by WHO for bioequivalence study activities, including clinical operations, bioanalytical operations, statistics, documentation, SOPs, computer systems, sample handling, and GCP/GLP-related processes.

Core Services

Aizant provides API R&D services focused on route design, process optimization, impurity profiling, analytical support, and development pathways for small-molecule programs. Their API R&D facility includes chemical and analytical laboratories, oncology and HPAPI suites, and process development capabilities.

Their formulation development and CDMO services support pre-formulation, formulation development, analytical development, scale-up, clinical manufacturing, and finished dosage manufacturing. Aizant’s formulation capabilities span both conventional and novel drug delivery products, with support for analytical evaluation and regulatory documentation.

Aizant also provides clinical research services, including bioavailability and bioequivalence studies, bioanalysis, pharmacokinetics, biostatistics, and clinical trial support. Their clinical facility has a reported 190-bed capacity and supports Phase I–IV clinical trial work.

Technology & Expertise

Aizant’s expertise is centered on integrated drug development. Their platform connects API R&D, formulation development, analytical testing, bioanalytical services, clinical research, manufacturing, and regulatory support so sponsors can reduce handoffs between separate vendors.

Their API R&D capabilities are especially relevant for programs that need route scouting, process development, impurity control, oncology or high-potency API support, and regulatory-ready documentation. Their formulation and manufacturing capabilities are useful for sponsors moving from early feasibility into clinical supply, scale-up, and commercial manufacturing.

Aizant’s clinical and bioanalytical operations support BA/BE studies, PK analysis, sample testing, statistics, and clinical reporting, making them a fit for sponsors that need development continuity from formulation through human study execution.

Best Fit Projects

Aizant is a strong fit for projects involving API R&D, small-molecule process development, impurity profiling, formulation development, analytical method development, stability studies, clinical manufacturing, commercial manufacturing, BA/BE studies, bioanalysis, pharmacokinetics, biostatistics, regulatory support, and finished dosage development.

They are especially well suited for sponsors that want an integrated partner across drug product development, clinical research, and manufacturing rather than managing separate vendors for each stage.

Why Work With Aizant Through CROaccess

Through CROaccess, sponsors can evaluate Aizant for API R&D, CDMO, CMO, formulation, clinical research, and bioanalytical projects while comparing fit against other qualified CROs, CDMOs, and specialty laboratories.

Aizant brings broad drug development infrastructure across research, clinical, and manufacturing workflows, while CROaccess helps sponsors manage vendor evaluation, proposal collection, documentation, communication, and project tracking in one centralized platform.